Skip to main content

Table 7 Indicators to assess aggregate RACF-level concordance: antidepressants

From: Evidence-based Medication knowledge Brokers in Residential Aged CarE (EMBRACE): protocol for a helix-counterbalanced randomised controlled trial

 

Indicators to assess aggregate RACF-level concordance

Corresponding Guideline recommendations

1

Residents using antidepressants have documentation of moderate or severe major depressive disorder

CR 9

2

Residents using antidepressants have documentation of individually targeted non-pharmacological management strategies that are currently in place

GPS 6

3

Residents using antidepressants have documentation of informed consent for use of the antidepressant

GPS 8

4

Residents using antidepressants have a documented date of next review for antidepressant treatment effectiveness

GPS 10

5

Residents using antidepressants have a current antidepressant adverse event monitoring protocol in place

GPS 36

6

Residents using antidepressants have used the current antidepressant for less than 6 months

CR 11

7

Residents using antidepressants for more than 6 months are currently having the antidepressant dose tapered

GPS 37

8

Residents using antidepressants for more than 6 months and not currently tapering have documentation of a review of the harms and benefits of antidepressants continuation

CR 11

  1. Abbreviations: RACF, residential aged care facility; GPS, good practice statement; CR, conditional recommendation. GPS and CR refer to those in the Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications in People Living with Dementia and in Residential Aged Care